Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.

Cancer biology & therapy - 3 Oct 2017

El Baroudi Mariama, Machiels Jean-Pascal, Schmitz Sandra

Abstract excerpt

The tumor suppressor gene TP53 is the most frequently mutated gene in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). It represents a known transcription factor that controls different microRNAs (miRNA) and target genes involved in the regulation of cellular stress, apoptosis and response to DNA damage. We used The Cancer Genome Atlas database to investigate the difference in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Datasets as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Down-Regulation

Share to Gene Regulatory Networks

Share to Head and Neck Neoplasms

Share to Heat-Shock Proteins

Share to Kaplan-Meier Estimate

Share to Squamous Cell Carcinoma of Head and Neck

Source

Open in PubMed Open full text

Identifiers

PMID: 28886272
DOI: 10.1080/15384047.2017.1373212
PMCID: PMC5678692

Genes

SESN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.PMID 28886272Read ↗

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.Semantic proximity Read ↗

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Significance of TP53 mutation in treatment and prognosis in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer.Semantic proximity Read ↗

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.Semantic proximity Read ↗

TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.Semantic proximity Read ↗

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell CancerSemantic proximity Read ↗

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.Semantic proximity Read ↗

Long non‑coding RNA LOC541471: A novel prognostic biomarker for head and neck squamous cell carcinomaSemantic proximity Read ↗

Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.Semantic proximity Read ↗

High-risk TP53 mutations predict poor primary treatment response of patients with head and neck squamous cell carcinoma.Semantic proximity Read ↗

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.